Vimarsana
Biggest News Aggregation in the World

Nov Sant News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nov Sant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nov Sant Today - Breaking & Trending Today

Kinvent Secures Major Investment for Connected PT Solution - Vimarsana News

Kinvent Secures Major Investment for Connected PT Solution

Kinvent, known in Europe for its connected physical therapy solutions, secured funding it plans to use to penetrate the US market in 2024.

Eurazeo acquires a stake in Oncodesign Services - Vimarsana News

Eurazeo acquires a stake in Oncodesign Services

On Tuesday, investment group Eurazeo announced that it had acquired a stake in Oncodesign Services, a company specializing in drug discovery and pre-clinical services in oncology and...

Eurazeo: first investment in Kinvent -January 18, 2024 at 03:28 am EST - Vimarsana News

Eurazeo: first investment in Kinvent -January 18, 2024 at 03:28 am EST

The Nov Santé Actions Non Cotées fund, managed by Eurazeo and dedicated to the development of healthcare sectors in Europe, has announced the completion of its first growth equity investment in...

Related Topics:
Nov SantActions Non Cot
CAC40: back to 7400 pts, with the luxury sector in support -January 18, 2024 at 11:53 am EST - Vimarsana News

CAC40: back to 7400 pts, with the luxury sector in support -January 18, 2024 at 11:53 am EST

The Paris Bourse ended the session up 1.13% at 7,401 points, helped by a rebound in the luxury goods sector with +2.5% for LVMH, +2.2% for Kering and +1.8% for Hermès. On the statistics front, the...

SEQENS makes multi-million-dollar investment in U.S. R&D laboratory - Vimarsana News

SEQENS makes multi-million-dollar investment in U.S. R&D laboratory

SEQENS, an integrated leader in the manufacturing of active ingredients and pharmaceutical intermediates, announced a multi-million-dollar investment in its research and development laboratory located in Devens, Mass.